PURE Bioscience, Inc.
PURE
$0.0688
$0.013825.09%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.86% | 11.79% | 14.47% | -36.33% | 28.78% |
| Total Depreciation and Amortization | -- | 5.56% | -2.70% | 0.00% | 146.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.00% | -58.70% | 43.75% | -20.00% | -77.65% |
| Change in Net Operating Assets | 48.28% | -23.68% | 533.33% | -89.89% | 309.41% |
| Cash from Operations | 15.18% | 3.58% | 30.35% | -100.68% | 40.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | 0.00% | -- | -100.00% | -22.66% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 0.00% | -- | -100.00% | -22.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.77% | 19.13% | 86.98% | -355.94% | 9.87% |
